C
Labcorp Holdings Inc.
LH
$253.03
-$1.04-0.41%
C
Hold
1/8/2025Upgraded
Labcorp Holdings Inc. (LH) was upgraded to C from C- on 1/8/2025 due to a noticeable increase in the total return index, volatility index and solvency index. The quick ratio increased from 0.62 to 1.1.
Labcorp Holdings Inc. (LH) was upgraded to C from C- on 1/8/2025 due to a noticeable increase in the total return index, volatility index and solvency index. The quick ratio increased from 0.62 to 1.1.
C
Hold
8/22/2024Upgraded
Labcorp Holdings Inc. (LH) was upgraded to C- from D+ on 8/22/2024 due to an increase in the volatility index and total return index.
Labcorp Holdings Inc. (LH) was upgraded to C- from D+ on 8/22/2024 due to an increase in the volatility index and total return index.
D
Sell
8/7/2024Downgrade
Labcorp Holdings Inc. (LH) was downgraded to D+ from C- on 8/7/2024 due to a decline in the volatility index, total return index and solvency index.
Labcorp Holdings Inc. (LH) was downgraded to D+ from C- on 8/7/2024 due to a decline in the volatility index, total return index and solvency index.
C
Hold
2/28/2024Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C- from C on 2/28/2024 due to a noticeable decline in the valuation index, growth index and efficiency index. Earnings per share declined from $2.11 to -$1.9702, net income declined 191.16% from $183.3M to -$167.1M, and EBIT declined 19.11% from $270M to $218.4M.
Laboratory Corporation of America Holdings (LH) was downgraded to C- from C on 2/28/2024 due to a noticeable decline in the valuation index, growth index and efficiency index. Earnings per share declined from $2.11 to -$1.9702, net income declined 191.16% from $183.3M to -$167.1M, and EBIT declined 19.11% from $270M to $218.4M.
C
Hold
1/4/2024Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to C from C- on 1/4/2024 due to an increase in the total return index and volatility index.
Laboratory Corporation of America Holdings (LH) was upgraded to C from C- on 1/4/2024 due to an increase in the total return index and volatility index.
C
Hold
10/31/2023Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C- from C on 10/31/2023 due to a significant decline in the growth index, volatility index and valuation index. EBIT declined 5.23% from $284.9M to $270M, and earnings per share declined from $2.1209 to $2.11.
Laboratory Corporation of America Holdings (LH) was downgraded to C- from C on 10/31/2023 due to a significant decline in the growth index, volatility index and valuation index. EBIT declined 5.23% from $284.9M to $270M, and earnings per share declined from $2.1209 to $2.11.
C
Hold
7/18/2023Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C from C+ on 7/18/2023 due to a decline in the volatility index and total return index.
Laboratory Corporation of America Holdings (LH) was downgraded to C from C+ on 7/18/2023 due to a decline in the volatility index and total return index.
C
Hold
6/29/2023Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to C+ from C on 6/29/2023 due to an increase in the volatility index.
Laboratory Corporation of America Holdings (LH) was upgraded to C+ from C on 6/29/2023 due to an increase in the volatility index.
C
Hold
6/14/2023Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C from C+ on 6/14/2023 due to a decline in the volatility index, valuation index and solvency index.
Laboratory Corporation of America Holdings (LH) was downgraded to C from C+ on 6/14/2023 due to a decline in the volatility index, valuation index and solvency index.
C
Hold
4/25/2023Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 4/25/2023 due to a decline in the total return index, valuation index and dividend index.
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 4/25/2023 due to a decline in the total return index, valuation index and dividend index.
B
Buy
4/3/2023Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 4/3/2023 due to an increase in the volatility index and dividend index.
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 4/3/2023 due to an increase in the volatility index and dividend index.
C
Hold
8/3/2022Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 8/3/2022 due to a decline in the valuation index, solvency index and volatility index. Debt to equity increased from 0.52 to 0.54, and the quick ratio declined from 1.62 to 1.56.
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 8/3/2022 due to a decline in the valuation index, solvency index and volatility index. Debt to equity increased from 0.52 to 0.54, and the quick ratio declined from 1.62 to 1.56.
B
Buy
7/28/2022Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 7/28/2022 due to an increase in the total return index.
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 7/28/2022 due to an increase in the total return index.
C
Hold
7/13/2022Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 7/13/2022 due to a decline in the total return index, volatility index and valuation index.
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 7/13/2022 due to a decline in the total return index, volatility index and valuation index.
B
Buy
6/14/2022Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to B- from B on 6/14/2022 due to a substantial decline in the growth index, total return index and valuation index. Operating cash flow declined 48.96% from $697.5M to $356M, EBIT declined 12.53% from $802.2M to $701.7M, and earnings per share declined from $5.7604 to $5.23.
Laboratory Corporation of America Holdings (LH) was downgraded to B- from B on 6/14/2022 due to a substantial decline in the growth index, total return index and valuation index. Operating cash flow declined 48.96% from $697.5M to $356M, EBIT declined 12.53% from $802.2M to $701.7M, and earnings per share declined from $5.7604 to $5.23.
B
Buy
7/23/2021Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to B from B- on 7/23/2021 due to a substantial increase in the valuation index, solvency index and total return index. Debt to equity declined from 0.64 to 0.56, and the quick ratio increased from 1.41 to 1.42.
Laboratory Corporation of America Holdings (LH) was upgraded to B from B- on 7/23/2021 due to a substantial increase in the valuation index, solvency index and total return index. Debt to equity declined from 0.64 to 0.56, and the quick ratio increased from 1.41 to 1.42.
B
Buy
11/30/2020Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 11/30/2020 due to an increase in the volatility index, valuation index and total return index.
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 11/30/2020 due to an increase in the volatility index, valuation index and total return index.
C
Hold
11/9/2020Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to C+ from C on 11/9/2020 due to a significant increase in the growth index, valuation index and total return index. EBIT increased 242.28% from $316.7M to $1.08B, earnings per share increased from $2.37 to $7.17, and operating cash flow increased 112.09% from $370.7M to $786.2M.
Laboratory Corporation of America Holdings (LH) was upgraded to C+ from C on 11/9/2020 due to a significant increase in the growth index, valuation index and total return index. EBIT increased 242.28% from $316.7M to $1.08B, earnings per share increased from $2.37 to $7.17, and operating cash flow increased 112.09% from $370.7M to $786.2M.
C
Hold
7/31/2020Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to C from C- on 7/31/2020 due to a noticeable increase in the growth index, total return index and solvency index. Earnings per share increased from -$3.27 to $2.37, operating cash flow increased 81.89% from $203.8M to $370.7M, and EBIT increased 12.19% from $282.3M to $316.7M.
Laboratory Corporation of America Holdings (LH) was upgraded to C from C- on 7/31/2020 due to a noticeable increase in the growth index, total return index and solvency index. Earnings per share increased from -$3.27 to $2.37, operating cash flow increased 81.89% from $203.8M to $370.7M, and EBIT increased 12.19% from $282.3M to $316.7M.
C
Hold
5/12/2020Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C- from C on 5/12/2020 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $2.3118 to -$3.27, operating cash flow declined 64.23% from $569.8M to $203.8M, and EBIT declined 23.16% from $367.4M to $282.3M.
Laboratory Corporation of America Holdings (LH) was downgraded to C- from C on 5/12/2020 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $2.3118 to -$3.27, operating cash flow declined 64.23% from $569.8M to $203.8M, and EBIT declined 23.16% from $367.4M to $282.3M.
C
Hold
3/12/2020Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C from C+ on 3/12/2020 due to a noticeable decline in the volatility index and total return index.
Laboratory Corporation of America Holdings (LH) was downgraded to C from C+ on 3/12/2020 due to a noticeable decline in the volatility index and total return index.
C
Hold
3/3/2020Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 3/3/2020 due to a decline in the volatility index and solvency index. The quick ratio declined from 0.96 to 0.89.
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 3/3/2020 due to a decline in the volatility index and solvency index. The quick ratio declined from 0.96 to 0.89.
B
Buy
2/18/2020Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 2/18/2020 due to an increase in the volatility index, growth index and efficiency index.
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 2/18/2020 due to an increase in the volatility index, growth index and efficiency index.
C
Hold
1/30/2020Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 1/30/2020 due to a decline in the valuation index and volatility index.
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 1/30/2020 due to a decline in the valuation index and volatility index.
B
Buy
1/10/2020Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 1/10/2020 due to an increase in the total return index.
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 1/10/2020 due to an increase in the total return index.
C
Hold
12/23/2019Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 12/23/2019 due to a decline in the total return index and volatility index.
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 12/23/2019 due to a decline in the total return index and volatility index.
B
Buy
11/29/2019Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 11/29/2019 due to a noticeable increase in the volatility index, total return index and growth index. Operating cash flow increased 79.72% from $253.5M to $455.6M, earnings per share increased from $1.93 to $2.25, and total revenue increased 1.62% from $2.88B to $2.93B.
Laboratory Corporation of America Holdings (LH) was upgraded to B- from C+ on 11/29/2019 due to a noticeable increase in the volatility index, total return index and growth index. Operating cash flow increased 79.72% from $253.5M to $455.6M, earnings per share increased from $1.93 to $2.25, and total revenue increased 1.62% from $2.88B to $2.93B.
C
Hold
5/15/2019Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to C+ from C on 5/15/2019 due to an increase in the volatility index.
Laboratory Corporation of America Holdings (LH) was upgraded to C+ from C on 5/15/2019 due to an increase in the volatility index.
C
Hold
12/28/2018Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C from C+ on 12/28/2018 due to a decline in the volatility index and total return index.
Laboratory Corporation of America Holdings (LH) was downgraded to C from C+ on 12/28/2018 due to a decline in the volatility index and total return index.
C
Hold
12/17/2018Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 12/17/2018 due to a decline in the volatility index and total return index.
Laboratory Corporation of America Holdings (LH) was downgraded to C+ from B- on 12/17/2018 due to a decline in the volatility index and total return index.
B
Buy
12/6/2018Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to B- from B on 12/6/2018 due to a major decline in the volatility index, growth index and total return index. Operating cash flow declined 19.14% from $367.3M to $297M, EBIT declined 10.69% from $405.1M to $361.8M, and total revenue declined 1.22% from $2.87B to $2.83B.
Laboratory Corporation of America Holdings (LH) was downgraded to B- from B on 12/6/2018 due to a major decline in the volatility index, growth index and total return index. Operating cash flow declined 19.14% from $367.3M to $297M, EBIT declined 10.69% from $405.1M to $361.8M, and total revenue declined 1.22% from $2.87B to $2.83B.
B
Buy
9/24/2018Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to B from B+ on 9/24/2018 due to a noticeable decline in the total return index and volatility index.
Laboratory Corporation of America Holdings (LH) was downgraded to B from B+ on 9/24/2018 due to a noticeable decline in the total return index and volatility index.
B
Buy
8/28/2018Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to B+ from A- on 8/28/2018 due to a noticeable decline in the total return index.
Laboratory Corporation of America Holdings (LH) was downgraded to B+ from A- on 8/28/2018 due to a noticeable decline in the total return index.
A
Buy
8/14/2018Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to A- from A on 8/14/2018 due to a decline in the total return index.
Laboratory Corporation of America Holdings (LH) was downgraded to A- from A on 8/14/2018 due to a decline in the total return index.
A
Buy
7/27/2018Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to A from A- on 7/27/2018 due to a noticeable increase in the growth index, total return index and valuation index. Operating cash flow increased 137.43% from $154.7M to $367.3M, earnings per share increased from $1.67 to $2.27, and EBIT increased 8.49% from $373.4M to $405.1M.
Laboratory Corporation of America Holdings (LH) was upgraded to A from A- on 7/27/2018 due to a noticeable increase in the growth index, total return index and valuation index. Operating cash flow increased 137.43% from $154.7M to $367.3M, earnings per share increased from $1.67 to $2.27, and EBIT increased 8.49% from $373.4M to $405.1M.
A
Buy
7/11/2018Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to A- from B+ on 7/11/2018 due to an increase in the volatility index and total return index.
Laboratory Corporation of America Holdings (LH) was upgraded to A- from B+ on 7/11/2018 due to an increase in the volatility index and total return index.
B
Buy
5/21/2018Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to B+ from B on 5/21/2018 due to an increase in the volatility index and solvency index. The quick ratio increased from 0.99 to 1.1, and debt to equity declined from 0.98 to 0.96.
Laboratory Corporation of America Holdings (LH) was upgraded to B+ from B on 5/21/2018 due to an increase in the volatility index and solvency index. The quick ratio increased from 0.99 to 1.1, and debt to equity declined from 0.98 to 0.96.
B
Buy
4/2/2018Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to B from B+ on 4/2/2018 due to a decline in the total return index and volatility index.
Laboratory Corporation of America Holdings (LH) was downgraded to B from B+ on 4/2/2018 due to a decline in the total return index and volatility index.
B
Buy
3/19/2018Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to B+ from A on 3/19/2018 due to a decline in the volatility index and valuation index.
Laboratory Corporation of America Holdings (LH) was downgraded to B+ from A on 3/19/2018 due to a decline in the volatility index and valuation index.
A
Buy
3/5/2018Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to A from B on 3/5/2018 due to a large increase in the growth index, valuation index and total return index. Earnings per share increased from $1.74 to $6.8231, operating cash flow increased 60.73% from $350.9M to $564M, and EBIT increased 5.69% from $391.9M to $414.2M.
Laboratory Corporation of America Holdings (LH) was upgraded to A from B on 3/5/2018 due to a large increase in the growth index, valuation index and total return index. Earnings per share increased from $1.74 to $6.8231, operating cash flow increased 60.73% from $350.9M to $564M, and EBIT increased 5.69% from $391.9M to $414.2M.
B
Buy
2/23/2018Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to B from B+ on 2/23/2018 due to a decline in the valuation index and volatility index.
Laboratory Corporation of America Holdings (LH) was downgraded to B from B+ on 2/23/2018 due to a decline in the valuation index and volatility index.
B
Buy
11/30/2017Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to B+ from B on 11/30/2017 due to an increase in the volatility index.
Laboratory Corporation of America Holdings (LH) was upgraded to B+ from B on 11/30/2017 due to an increase in the volatility index.
B
Buy
10/5/2017Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to B from B+ on 10/5/2017 due to a decline in the total return index.
Laboratory Corporation of America Holdings (LH) was downgraded to B from B+ on 10/5/2017 due to a decline in the total return index.
B
Buy
8/15/2017Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to B+ from B on 8/15/2017 due to an increase in the total return index, growth index and volatility index. Operating cash flow increased 32.89% from $233.8M to $310.7M, EBIT increased 12.28% from $343.7M to $385.9M, and total revenue increased 3.75% from $2.41B to $2.5B.
Laboratory Corporation of America Holdings (LH) was upgraded to B+ from B on 8/15/2017 due to an increase in the total return index, growth index and volatility index. Operating cash flow increased 32.89% from $233.8M to $310.7M, EBIT increased 12.28% from $343.7M to $385.9M, and total revenue increased 3.75% from $2.41B to $2.5B.
B
Buy
6/20/2017Downgrade
Laboratory Corporation of America Holdings (LH) was downgraded to B from B+ on 6/20/2017 due to a decline in the total return index and valuation index.
Laboratory Corporation of America Holdings (LH) was downgraded to B from B+ on 6/20/2017 due to a decline in the total return index and valuation index.
B
Buy
6/5/2017Upgraded
Laboratory Corporation of America Holdings (LH) was upgraded to B+ from B on 6/5/2017 due to an increase in the total return index, valuation index and volatility index.
Laboratory Corporation of America Holdings (LH) was upgraded to B+ from B on 6/5/2017 due to an increase in the total return index, valuation index and volatility index.
B
Buy
10/28/2016Downgrade
Laboratory Corp. of America Holdings (LH) was downgraded to B from B+ on 10/28/2016 due to a noticeable decline in the total return index and volatility index.
Laboratory Corp. of America Holdings (LH) was downgraded to B from B+ on 10/28/2016 due to a noticeable decline in the total return index and volatility index.
B
Buy
7/29/2016Upgraded
Laboratory Corp. of America Holdings (LH) was upgraded to B+ from B on 7/29/2016 due to a significant increase in the total return index, growth index and volatility index. Operating cash flow increased 179.35% from $123M to $343.6M, earnings per share increased from $1.55 to $1.91, and EBIT increased 15.16% from $331.2M to $381.4M.
Laboratory Corp. of America Holdings (LH) was upgraded to B+ from B on 7/29/2016 due to a significant increase in the total return index, growth index and volatility index. Operating cash flow increased 179.35% from $123M to $343.6M, earnings per share increased from $1.55 to $1.91, and EBIT increased 15.16% from $331.2M to $381.4M.
B
Buy
5/19/2016Upgraded
Laboratory Corp. of America Holdings (LH) was upgraded to B from B- on 5/19/2016 due to an increase in the volatility index and total return index.
Laboratory Corp. of America Holdings (LH) was upgraded to B from B- on 5/19/2016 due to an increase in the volatility index and total return index.
B
Buy
5/6/2016Upgraded
Laboratory Corp. of America Holdings (LH) was upgraded to B- from C on 5/6/2016 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from $1.1005 to $1.55, the quick ratio increased from 1.23 to 1.34, and EBIT increased 5.78% from $313.1M to $331.2M.
Laboratory Corp. of America Holdings (LH) was upgraded to B- from C on 5/6/2016 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from $1.1005 to $1.55, the quick ratio increased from 1.23 to 1.34, and EBIT increased 5.78% from $313.1M to $331.2M.
C
Hold
3/8/2016Downgrade
Laboratory Corp. of America Holdings (LH) was downgraded to C from C+ on 3/8/2016 due to a decline in the volatility index, growth index and total return index. Earnings per share declined from $1.49 to $1.1005, EBIT declined 7.48% from $338.4M to $313.1M, and total revenue declined 1.11% from $2.27B to $2.24B.
Laboratory Corp. of America Holdings (LH) was downgraded to C from C+ on 3/8/2016 due to a decline in the volatility index, growth index and total return index. Earnings per share declined from $1.49 to $1.1005, EBIT declined 7.48% from $338.4M to $313.1M, and total revenue declined 1.11% from $2.27B to $2.24B.
C
Hold
1/13/2016Downgrade
Laboratory Corp. of America Holdings (LH) was downgraded to C+ from B- on 1/13/2016 due to a decline in the volatility index.
Laboratory Corp. of America Holdings (LH) was downgraded to C+ from B- on 1/13/2016 due to a decline in the volatility index.
B
Buy
12/29/2015Upgraded
Laboratory Corp. of America Holdings (LH) was upgraded to B- from C+ on 12/29/2015 due to an increase in the volatility index.
Laboratory Corp. of America Holdings (LH) was upgraded to B- from C+ on 12/29/2015 due to an increase in the volatility index.
C
Hold
12/14/2015Downgrade
Laboratory Corp. of America Holdings (LH) was downgraded to C+ from B- on 12/14/2015 due to a noticeable decline in the volatility index and valuation index.
Laboratory Corp. of America Holdings (LH) was downgraded to C+ from B- on 12/14/2015 due to a noticeable decline in the volatility index and valuation index.
B
Buy
10/30/2015Downgrade
Laboratory Corp. of America Holdings (LH) was downgraded to B- from B on 10/30/2015 due to a noticeable decline in the volatility index, solvency index and total return index.
Laboratory Corp. of America Holdings (LH) was downgraded to B- from B on 10/30/2015 due to a noticeable decline in the volatility index, solvency index and total return index.
B
Buy
5/6/2015Downgrade
Laboratory Corp. of America Holdings (LH) was downgraded to B from B+ on 5/6/2015 due to a large decline in the growth index, valuation index and efficiency index. Operating cash flow declined 140.66% from $213.7M to -$86.9M, earnings per share declined from $1.3763 to $0.0076, and net income declined 99.41% from $119.6M to $700.
Laboratory Corp. of America Holdings (LH) was downgraded to B from B+ on 5/6/2015 due to a large decline in the growth index, valuation index and efficiency index. Operating cash flow declined 140.66% from $213.7M to -$86.9M, earnings per share declined from $1.3763 to $0.0076, and net income declined 99.41% from $119.6M to $700.
B
Buy
4/2/2015Upgraded
Laboratory Corp. of America Holdings (LH) was upgraded to B+ from B on 4/2/2015 due to a noticeable increase in the volatility index, total return index and growth index. Operating cash flow increased 21.7% from $175.6M to $213.7M.
Laboratory Corp. of America Holdings (LH) was upgraded to B+ from B on 4/2/2015 due to a noticeable increase in the volatility index, total return index and growth index. Operating cash flow increased 21.7% from $175.6M to $213.7M.
B
Buy
2/24/2015Upgraded
Laboratory Corp. of America Holdings (LH) was upgraded to B from B- on 2/24/2015 due to an increase in the volatility index and total return index.
Laboratory Corp. of America Holdings (LH) was upgraded to B from B- on 2/24/2015 due to an increase in the volatility index and total return index.
B
Buy
2/9/2015Downgrade
Laboratory Corp. of America Holdings (LH) was downgraded to B- from B on 2/9/2015 due to a decline in the volatility index.
Laboratory Corp. of America Holdings (LH) was downgraded to B- from B on 2/9/2015 due to a decline in the volatility index.
B
Buy
1/22/2015Upgraded
Laboratory Corp. of America Holdings (LH) was upgraded to B from B- on 1/22/2015 due to an increase in the volatility index and total return index.
Laboratory Corp. of America Holdings (LH) was upgraded to B from B- on 1/22/2015 due to an increase in the volatility index and total return index.
B
Buy
12/12/2014Downgrade
Laboratory Corp. of America Holdings (LH) was downgraded to B- from B on 12/12/2014 due to a major decline in the growth index, volatility index and total return index. Operating cash flow declined 15.33% from $207.4M to $175.6M, earnings per share declined from $1.64 to $1.59, and EBIT declined 0.32% from $253.4M to $252.6M.
Laboratory Corp. of America Holdings (LH) was downgraded to B- from B on 12/12/2014 due to a major decline in the growth index, volatility index and total return index. Operating cash flow declined 15.33% from $207.4M to $175.6M, earnings per share declined from $1.64 to $1.59, and EBIT declined 0.32% from $253.4M to $252.6M.
B
Buy
9/23/2014Downgrade
Laboratory Corp. of America Holdings (LH) was downgraded to B from B+ on 9/23/2014 due to a decline in the volatility index and total return index.
Laboratory Corp. of America Holdings (LH) was downgraded to B from B+ on 9/23/2014 due to a decline in the volatility index and total return index.
B
Buy
9/8/2014Upgraded
Laboratory Corp. of America Holdings (LH) was upgraded to B+ from B on 9/8/2014 due to a substantial increase in the growth index, volatility index and solvency index. Operating cash flow increased 45.75% from $142.3M to $207.4M, earnings per share increased from $1.31 to $1.64, and EBIT increased 20.15% from $210.9M to $253.4M.
Laboratory Corp. of America Holdings (LH) was upgraded to B+ from B on 9/8/2014 due to a substantial increase in the growth index, volatility index and solvency index. Operating cash flow increased 45.75% from $142.3M to $207.4M, earnings per share increased from $1.31 to $1.64, and EBIT increased 20.15% from $210.9M to $253.4M.
B
Buy
5/29/2014Upgraded
Laboratory Corp. of America Holdings (LH) was upgraded to B from B- on 5/29/2014 due to a noticeable increase in the volatility index.
Laboratory Corp. of America Holdings (LH) was upgraded to B from B- on 5/29/2014 due to a noticeable increase in the volatility index.
NYSE
03/07/2025 4:00PM Eastern
Quotes delayed
